NDC 70518-0469

REYATAZ

Atazanavir

REYATAZ is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Atazanavir Sulf.

Product ID70518-0469_5e869547-4459-8bab-e053-2a91aa0a652c
NDC70518-0469
Product TypeHuman Prescription Drug
Proprietary NameREYATAZ
Generic NameAtazanavir
Dosage FormCapsule, Gelatin Coated
Route of AdministrationORAL
Marketing Start Date2017-05-09
Marketing CategoryNDA / NDA
Application NumberNDA021567
Labeler NameREMEDYREPACK INC.
Substance NameATAZANAVIR SULF
Active Ingredient Strength300 mg/1
Pharm ClassesHIV Protease In
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 70518-0469-0

30 CAPSULE, GELATIN COATED in 1 BLISTER PACK (70518-0469-0)
Marketing Start Date2017-04-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-0469-0 [70518046900]

REYATAZ CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA021567
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-04-28
Marketing End Date2020-04-06

Drug Details

Active Ingredients

IngredientStrength
ATAZANAVIR SULFATE300 mg/1

OpenFDA Data

SPL SET ID:b75a68d8-c2ed-4439-8987-8e168fe9f055
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 664741
  • 664743

    • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • UGT1A1 Inhibitors [MoA]
    • UDP Glucuronosyltransferases Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]

    NDC Crossover Matching brand name "REYATAZ" or generic name "Atazanavir"

    NDCBrand NameGeneric Name
    0003-3622REYATAZATAZANAVIR
    0003-3624REYATAZATAZANAVIR
    0003-3631REYATAZATAZANAVIR
    0003-3638REYATAZATAZANAVIR
    50090-1007REYATAZATAZANAVIR
    50090-1581REYATAZATAZANAVIR
    69189-3631REYATAZREYATAZ
    69189-3624REYATAZREYATAZ
    70518-0725REYATAZREYATAZ
    70518-0688REYATAZREYATAZ
    70518-0469REYATAZREYATAZ
    67296-1236REYATAZREYATAZ
    31722-653AtazanavirAtazanavir
    31722-654AtazanavirAtazanavir
    31722-655AtazanavirAtazanavir
    42385-920AtazanavirAtazanavir
    42385-921AtazanavirAtazanavir
    42385-922AtazanavirAtazanavir
    59762-0408ATAZANAVIRATAZANAVIR
    59762-0409ATAZANAVIRATAZANAVIR
    59762-0410ATAZANAVIRATAZANAVIR
    0904-6875Atazanavir SulfateAtazanavir
    16714-860Atazanavir SulfateAtazanavir
    16714-861Atazanavir SulfateAtazanavir
    16714-862Atazanavir SulfateAtazanavir
    60687-399Atazanavir SulfateAtazanavir
    65862-710Atazanavir SulfateAtazanavir
    65862-711Atazanavir SulfateAtazanavir

    Trademark Results [REYATAZ]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    REYATAZ
    REYATAZ
    78804555 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2006-02-01
    REYATAZ
    REYATAZ
    78169764 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2002-10-01
    REYATAZ
    REYATAZ
    78169761 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2002-10-01
    REYATAZ
    REYATAZ
    78169757 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2002-10-01
    REYATAZ
    REYATAZ
    78169754 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2002-10-01
    REYATAZ
    REYATAZ
    78131406 2846482 Live/Registered
    Bristol-Myers Squibb Company
    2002-05-28
    REYATAZ
    REYATAZ
    77829869 4415058 Live/Registered
    Bristol-Myers Squibb Company
    2009-09-18
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.